{"article": [{"url": "https://www.marketwatch.com/story/johnson-johnson-stock-rises-wednesday-still-underperforms-market-01602102332", "published": 1602088400.0, "headline": "Johnson & Johnson stock rises Wednesday, still underperforms market", "body": "Shares of Johnson & Johnson JNJ, +1.39% rose 1.11% to $147.88 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, +0.87% rising 1.74% to 3,419.44 and the Dow Jones Industrial Average DJIA, +0.56% rising 1.91% to 28,303.46. Johnson & Johnson closed $9.12 below its 52-week high ($157.00), which the company achieved on April 23rd. The stock outperformed some of its competitors Wednesday, as Roche Holding AG Part. Cert. RHHVF, +2.93% fell 0.22% to $343.50, Merck & Co. Inc. MRK, -0.14% rose 0.51% to $80.04, and Pfizer Inc. PFE, -0.27% rose 0.83% to $36.47. Trading volume (5.4 M) remained 382,049 below its 50-day average volume of 5.8 M. Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use."}]}